CIK 0001326190 · Non-accelerated filer<br>Smaller reporting company
Altimmune, Inc.
Sign in to watch- Ticker
- ALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 202726770
- Phone
- 862-457-1450
- Business address
- 350 MOUNT KEMBLE AVENUE, SUITE 1001, MORRISTOWN, NJ, 07960
- Former names
- PHARMATHENE, INC, HEALTHCARE ACQUISITION CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-01 | Jordt Raymond M Chief Business Officer | Option exercise · Restricted Stock Units | −9,375 | 28,125 | ||
| 2023-12-29 | Eisenstadt Richard I Chief Financial Officer | Option exercise | +12,500 | 36,335 | ||
| 2023-12-29 | Eisenstadt Richard I Chief Financial Officer | Shares withheld for taxes | −3,044 | $11.25 | $34K | 33,291 |
| 2023-12-29 | Eisenstadt Richard I Chief Financial Officer | Option exercise · Restricted Stock Units | −12,500 | 25,000 | ||
| 2023-09-28 | Schafer Klaus Director | Grant or award · Stock Options (option to buy) | +26,100 | 26,100 | ||
| 2023-09-28 | Drutz David Director | Grant or award · Stock Options (option to buy) | +26,100 | 26,100 | ||
| 2023-09-28 | Hodges Philip Director | Grant or award · Stock Options (option to buy) | +26,100 | 26,100 | ||
| 2023-09-28 | Sohn Catherine A. Director | Grant or award · Stock Options (option to buy) | +26,100 | 26,100 | ||
| 2023-09-28 | GILL JOHN Director | Grant or award · Stock Options (option to buy) | +26,100 | 26,100 | ||
| 2023-09-28 | SAYARE MITCHEL Director | Grant or award · Stock Options (option to buy) | +26,100 | 26,100 | ||
| 2023-09-28 | Jorkasky Diane Director | Grant or award · Stock Options (option to buy) | +26,100 | 26,100 | ||
| 2023-09-28 | Pisano Wayne Director | Grant or award · Stock Options (option to buy) | +26,100 | 26,100 | ||
| 2023-08-15 | Drutz David Director | Purchase | +300 | $2.88 | $863 | 29,785 |
| 2023-07-31 | Garg Vipin K President and CEO | Grant or award | +126 | $2.81 | $354 | 249,255 |
| 2023-07-31 | Eisenstadt Richard I Chief Financial Officer | Grant or award | +1,825 | $2.81 | $5K | 23,835 |
| 2023-07-31 | Harris Matthew Scott Chief Medical Officer | Grant or award | +691 | $2.81 | $2K | 34,002 |
| 2023-07-31 | Roberts M Scot Chief Scientific Officer | Grant or award | +568 | $2.81 | $2K | 20,424 |
| 2023-07-31 | Jordt Raymond M Chief Business Officer | Grant or award | +1,832 | $2.81 | $5K | 1,832 |
| 2023-03-24 | Eisenstadt Richard I Chief Financial Officer | Purchase | +10,000 | $4.31 | $43K | 22,010 |
| 2023-03-23 | Drutz David Director | Purchase | +9,000 | $4.27 | $38K | 29,484 |
Page 12 of 29 · 568 trades